p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes

Levine, 2006, The P53 pathway: What questions remain to be explored?, Cell Death Differ., 13, 1027, 10.1038/sj.cdd.4401910

Harris, 2005, The p53 pathway: Positive and negative feedback loops, Oncogene, 24, 2899, 10.1038/sj.onc.1208615

Valencia-Sanchez, 2006, Control of translation and mRNA degradation by miRNAs and siRNAs, Genes Dev., 20, 515, 10.1101/gad.1399806

Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035

Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc. Natl. Acad. Sci. USA, 103, 2257, 10.1073/pnas.0510565103

Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702

Cummins, 2006, The colorectal microRNAome, Proc. Natl. Acad. Sci. USA, 103, 3687, 10.1073/pnas.0511155103

He, 2005, A microRNA polycistron as a potential human oncogene, Nature, 435, 828, 10.1038/nature03552

O'Donnell, 2005, c-Myc-regulated microRNAs modulate E2F1 expression, Nature, 435, 839, 10.1038/nature03677

Kluiver, 2006, Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma, Oncogene, 26, 3769, 10.1038/sj.onc.1210147

Costinean, 2006, Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice, Proc. Natl. Acad. Sci. USA, 103, 7024, 10.1073/pnas.0602266103

Michael, 2003, Reduced accumulation of specific microRNAs in colorectal neoplasia, Mol. Cancer Res., 1, 882

Calin, 2002, Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia, Proc. Natl. Acad. Sci. USA, 99, 15524, 10.1073/pnas.242606799

Calin, 2005, A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia, N. Engl. J. Med., 353, 1793, 10.1056/NEJMoa050995

Cimmino, 2005, miR-15 and miR-16 induce apoptosis by targeting BCL2, Proc. Natl. Acad. Sci. USA, 102, 13944, 10.1073/pnas.0506654102

Mayr, 2007, Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation, Science, 315, 1576, 10.1126/science.1137999

Lee, 2007, The tumor suppressor microRNA let-7 represses the HMGA2 oncogene, Genes Dev., 21, 1025, 10.1101/gad.1540407

Johnson, 2005, RAS is regulated by the let-7 microRNA family, Cell, 120, 635, 10.1016/j.cell.2005.01.014

Kumar, 2007, Impaired microRNA processing enhances cellular transformation and tumorigenesis, Nat. Genet., 39, 673, 10.1038/ng2003

Wei, 2006, A global map of p53 transcription-factor binding sites in the human genome, Cell, 124, 207, 10.1016/j.cell.2005.10.043

Brummelkamp, 2002, A system for stable expression of short interfering RNAs in mammalian cells, Science, 296, 550, 10.1126/science.1068999

Baker, 1990, Suppression of human colorectal carcinoma cell growth by wild-type p53, Science, 249, 912, 10.1126/science.2144057

Polyak, 1996, Genetic determinants of p53-induced apoptosis and growth arrest, Genes Dev., 10, 1945, 10.1101/gad.10.15.1945

Farh, 2005, The widespread impact of mammalian MicroRNAs on mRNA repression and evolution, Science, 310, 1817, 10.1126/science.1121158

Lall, 2006, A genome-wide map of conserved microRNA targets in C. elegans, Curr. Biol., 16, 460, 10.1016/j.cub.2006.01.050

Krek, 2005, Combinatorial microRNA target predictions, Nat. Genet., 37, 495, 10.1038/ng1536

Miranda, 2006, A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes, Cell, 126, 1203, 10.1016/j.cell.2006.07.031

Welch, 2007, MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells, Oncogene, 10.1038/sj.onc.1210293

Schratt, 2004, SRF regulates Bcl-2 expression and promotes cell survival during murine embryonic development, EMBO J., 23, 1834, 10.1038/sj.emboj.7600188

Tammemagi, 1999, Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers, Cancer Epidemiol. Biomarkers Prev., 8, 625

Feng, 2007, Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation, Cancer Res., 67, 482, 10.1158/0008-5472.CAN-06-2314

Stryke, 2003, BayGenomics: A resource of insertional mutations in mouse embryonic stem cells, Nucleic Acids Res., 31, 278, 10.1093/nar/gkg064

Mortensen, 1992, Production of homozygous mutant ES cells with a single targeting construct, Mol. Cell. Biol., 12, 2391, 10.1128/MCB.12.5.2391

Bornkamm, 2005, Stringent doxycycline-dependent control of gene activities using an episomal one-vector system, Nucleic Acids Res., 33, e137, 10.1093/nar/gni137

Weinmann, 2001, Use of chromatin immunoprecipitation to clone novel E2F target promoters, Mol and Cell Biol., 21, 6820, 10.1128/MCB.21.20.6820-6832.2001